Showing 12 out of 2273 items
- Safety and effectiveness of long-acting cabotegravir for prevention in cisgender women
- Long-acting cabotegravir - focus on transgender women
- In context – long-acting cabotegravir for HIV prevention
- Learning from a case of breakthrough infection with long-acting cabotegravir for prevention
- Programming ConnectionThe National Overdose Response Service (NORS) provides 24/7 access to virtual overdose prevention services across Canada via the telephone.
- WebinarThis third webinar in a series on syphilis in Canada will review how doxy-PEP and doxy-PrEP are currently being used to prevent syphilis, as well as explore the concerns around their use and the…
- CATIE NewsSeveral factors in people with HIV can contribute to an increased risk for high blood pressure. Researchers studied 779 men, with and without HIV, to understand risks for high blood pressure. High…
- CATIE NewsInfections of the brain can arise in people with HIV who have very weak immune systems. A study found the risk of HIV-related death six times higher for HIV-positive people with a brain infection.…
- CATIE NewsTaking HIV PrEP before and after an exposure can greatly reduce the risk of infection. A U.S. study in young men found that one-third of all anal sex encounters were unpredicted. Long-acting forms of…
In this video, experienced service providers offer strengths-based and community-driven approaches for normalizing conversations around sex and drug use and meeting the unique needs of gbMSM,…- CATIE NewsDoxycycline is an antibiotic used to treat some bacterial sexually transmitted infections (STIs). Some people take the antibiotic to prevent STIs after a potential exposure; this is called doxyPEP. A…